My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 209

    1.

    Human TRIM5alpha mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants.

    Kaumanns P, Hagmann I, Dittmar MT.

    Retrovirology. 2006 Nov 6;3:79.PMID: 17087820 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lv2, a novel postentry restriction, is mediated by both capsid and envelope.

    Schmitz C, Marchant D, Neil SJ, Aubin K, Reuter S, Dittmar MT, McKnight A.

    J Virol. 2004 Feb;78(4):2006-16.PMID: 14747565 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Role of HIV-2 envelope in Lv2-mediated restriction.

    Reuter S, Kaumanns P, Buschhorn SB, Dittmar MT.

    Virology. 2005 Feb 5;332(1):347-58.PMID: 15661166 [PubMed - indexed for MEDLINE]Related articles

    4.

    A TRIM5alpha-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry.

    Pineda MJ, Orton BR, Overbaugh J.

    Virology. 2007 Jul 5;363(2):310-8. Epub 2007 Mar 9.PMID: 17350067 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.

    Yu D, Wang W, Yoder A, Spear M, Wu Y.

    PLoS Pathog. 2009 Oct;5(10):e1000633. Epub 2009 Oct 23.PMID: 19851458 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.

    Chazal N, Singer G, Aiken C, Hammarskjöld ML, Rekosh D.

    J Virol. 2001 Apr;75(8):4014-8.PMID: 11264394 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells.

    Hatziioannou T, Cowan S, Bieniasz PD.

    J Virol. 2004 Jan;78(2):1006-11.PMID: 14694132 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor.

    Chen J, Dang Q, Unutmaz D, Pathak VK, Maldarelli F, Powell D, Hu WS.

    J Virol. 2005 Apr;79(7):4140-9.PMID: 15767415 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.

    Sokolskaja E, Berthoux L, Luban J.

    J Virol. 2006 Mar;80(6):2855-62.PMID: 16501094 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1.

    Stremlau M, Song B, Javanbakht H, Perron M, Sodroski J.

    Virology. 2006 Jul 20;351(1):112-20. Epub 2006 Apr 27.PMID: 16643975 [PubMed - indexed for MEDLINE]Related articles

    13.

    APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.

    Pion M, Granelli-Piperno A, Mangeat B, Stalder R, Correa R, Steinman RM, Piguet V.

    J Exp Med. 2006 Dec 25;203(13):2887-93. Epub 2006 Dec 4.PMID: 17145955 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.

    Bartz SR, Vodicka MA.

    Methods. 1997 Aug;12(4):337-42.PMID: 9245614 [PubMed - indexed for MEDLINE]Related articles

    15.

    Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.

    Kuate S, Stahl-Hennig C, Stoiber H, Nchinda G, Floto A, Franz M, Sauermann U, Bredl S, Deml L, Ignatius R, Norley S, Racz P, Tenner-Racz K, Steinman RM, Wagner R, Uberla K.

    Virology. 2006 Jul 20;351(1):133-44. Epub 2006 Apr 17.PMID: 16616946 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.

    Keckesova Z, Ylinen LM, Towers GJ.

    J Virol. 2006 May;80(10):4683-90.PMID: 16641261 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus.

    Ohishi M, Shioda T, Sakuragi J.

    Virology. 2007 May 25;362(1):131-8. Epub 2007 Jan 26.PMID: 17258261 [PubMed - indexed for MEDLINE]Related articles

    19.

    Proteasomal degradation of TRIM5alpha during retrovirus restriction.

    Rold CJ, Aiken C.

    PLoS Pathog. 2008 May 23;4(5):e1000074.PMID: 18497858 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.

    Stremlau M, Perron M, Welikala S, Sodroski J.

    J Virol. 2005 Mar;79(5):3139-45.PMID: 15709033 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk